abioSCOPE® - True enabler of early detection
The abioSCOPE®, a near-patient rapid in vitro diagnostic platform, integrates seamlessly into clinical workflows.
Nanofluidic immunoassay technology enables the abioSCOPE® to deliver lab-quality quantitative, semi-quantitative, or qualitative results within minutes from a single drop (50 µL) of whole blood. The device reads a capsule-based cartridge containing test-specific biosensors, ensuring reliable performance and enabling accurate diagnostic decisions.
Reveal Sepsis Up to 72h Before Clinical Recognition
Our Rapid IVD Solution
The abioSCOPE® - a Benchtop Platform:
Results within minutes near-patient
Seamless integration into Hospital/Laboratory Systems
No sample-to-device contamination
The Disposable Capsule:
Based on Nanofluidic Immunoassay
Single-cartridge multiplex testing
Lab-Quality Results
Testimonials
Advantages
ONE DROP OF WHOLE BLOOD
50 μl of blood (capillary, venous or arterial whole blood) to perform a test on the abioSCOPE®.
LAB-QUALITY RESULTS WITHIN MINUTES
abioSCOPE® provides highly accurate, actionable results.
abioSCOPE® PLATFORM EASY DEVICE HANDLING
Low-maintenance and no sample-to-device contamination.
